Trusopt eye drops (Dorzolamide)

Brand Options

arrow pointer

Brand Name : Trusopt eye drops

Marketing Authorization Holder : Santen

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Dorzolamide

Manufactured By : Authorized UK Generic

Prescription Required

 
 

Product Details

Trusopt eye drops

Information about Trusopt Eye Drops (Dorzolamide)

Trusopt (Dorzolamide) is a topical medication used in the treatment of elevated intraocular pressure in conditions like glaucoma and ocular hypertension. It works by inhibiting the action of carbonic anhydrase, an enzyme that plays a key role in the production of aqueous humor (the fluid inside the eye). By reducing the amount of fluid produced in the eye, Trusopt helps lower intraocular pressure, thereby protecting the optic nerve from potential damage caused by high pressure.

Product Highlights

  • Trusopt is commonly prescribed for open-angle glaucoma, a condition where increased intraocular pressure can damage the optic nerve and lead to vision loss if untreated.
  • It is also used for the treatment of ocular hypertension, which is characterized by higher-than-normal intraocular pressure that can increase the risk of developing glaucoma.
  • Trusopt may be used in combination with other glaucoma medications to further reduce intraocular pressure, especially if a single medication is not sufficiently effective.

Key Ingredient

  • Dorzolamide

Key Benefits

  • The main benefit of Trusopt is its ability to lower elevated intraocular pressure, which is critical in preventing damage to the optic nerve in conditions like glaucoma.
  • By controlling intraocular pressure, Trusopt helps reduce the risk of vision loss and damage to the optic nerve.
  • Trusopt comes in the form of eye drops, which makes it easy to use and ideal for patients with difficulty taking oral medications.
  • Most patients tolerate Trusopt well, with mild or no systemic side effects.
  • It can be used in combination with other anti-glaucoma medications (such as beta-blockers or prostaglandins) for enhanced pressure-lowering effects.

Direction of Use

  • The typical dose of Trusopt is one drop in the affected eye(s) twice a day, in the morning and evening. Your doctor may adjust the dosage depending on your condition and response to treatment.
  • Gently pull down the lower eyelid and place one drop of Trusopt into the pocket formed by the eyelid. Close your eye gently after administration, and avoid blinking or rubbing the eye to ensure the medication stays in contact with the eye.
  • Make sure the tip of the dropper does not come into contact with your eye or any other surface to prevent contamination.
  • If you miss a dose, use it as soon as you recall, unless it's almost time for your next dose. Do not use two doses at once to make up for the missed dose.

Safety Concerns

  • Common side effects include eye irritation, stinging, or a burning sensation immediately after applying the drops. These effects usually go away with continued use.
  • Some people may experience temporary blurred vision after using the eye drops.
  • While Trusopt is primarily a topical treatment, some absorption into the bloodstream can occur, leading to potential systemic side effects such as tiredness, dizziness, or a metallic taste in the mouth.
  • Dorzolamide can affect kidney function, so it is important to monitor renal health during long-term use, especially in patients with pre-existing kidney conditions.
  • Since Dorzolamide is chemically related to sulfonamides, patients with a sulfonamide allergy should be cautious, as allergic reactions may occur.

Avoid Trusopt Eye Drops (Dorzolamide) If

  • You are allergic to Dorzolamide or any other sulfonamide drugs.
  • You have severe kidney problems or impaired renal function, as Trusopt may worsen kidney function.
  • You have low blood pH (acidosis), which may be aggravated by the medication.
  • You are pregnant or planning to become pregnant, unless advised by your doctor, as the safety of Trusopt during pregnancy has not been established.
  • You are breastfeeding, as it is not known whether Trusopt is excreted in breast milk, and the risks to the infant are not fully known.
  • You are using other carbonic anhydrase inhibitors (such as oral medications or other eye drops), as combining these medications could increase the risk of side effects.


Image Image Image Image